Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.
van der Weijst L, Machingura A, Alanya A, Lidington E, Velikova G, Flechtner HH, Schmidt H, Lehmann J, Ramage JK, Ringash J, Wac K, Oliver K, Taylor KJ, Wintner L, Senna LPC, Koller M, Husson O, Bultijnck R, Wilson R, Singer S, Bjelic-Radisic V, van der Graaf WTA, Pe M; EORTC Quality of Life Group. van der Weijst L, et al. Among authors: pe m. Eur J Cancer. 2024 Nov;212:114313. doi: 10.1016/j.ejca.2024.114313. Epub 2024 Sep 18. Eur J Cancer. 2024. PMID: 39305741 Free article. Review.
Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review.
Gross F, Rasmussen IML, Beisland EG, Jorem GT, Beisland C, Pappot H, Arraras JI, Pe M, Holzner B, Wintner LM; EORTC Quality of Life Group. Gross F, et al. Among authors: pe m. Eur Urol Oncol. 2024 Oct 3:S2588-9311(24)00215-3. doi: 10.1016/j.euo.2024.09.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39366818 Free article. Review.
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey.
Apolone G, Costantini M, Caselli L, Bos N, Caraceni A, Ciliberto G, Couespel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Garin O, Gilbert A, Machiavelli A, Marzorati C, Miceli R, Pe M, Petersen MA, Tanzilli A, van Schelven F, Dantas C, Minnée-van Braak I, Pinnavaia L, Brunelli C. Apolone G, et al. Among authors: pe m. BMC Public Health. 2024 Dec 18;24(1):3517. doi: 10.1186/s12889-024-21008-4. BMC Public Health. 2024. PMID: 39696103 Free PMC article.
Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe.
Amat-Fernandez C, Garin O, Luer-Aguila R, Pardo Y, Briseño R, Lizano-Barrantes C, Rojas-Concha L, S Y Thong M, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M; EUonQoL Working Group. Amat-Fernandez C, et al. Qual Life Res. 2025 Jan 23. doi: 10.1007/s11136-024-03884-w. Online ahead of print. Qual Life Res. 2025. PMID: 39847267 Review.
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.
Musoro J, Sleurs C, Rowsell A, Suciu S, Kicinski M, Chantziara S, Coens C, Pe M, Missotten P, Vandecruys E, Uyttebroeck A, Dresse MF, Pluchart C, Ferster A, Freycon C, Van Der Werff Ten Bosch J, Rohrlich P, Benoit Y, Piette C, Darlington AS; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLG) and Children's Leukemia Group (CLG). Musoro J, et al. Among authors: pe m. Pediatr Blood Cancer. 2025 Feb;72(2):e31446. doi: 10.1002/pbc.31446. Epub 2024 Nov 30. Pediatr Blood Cancer. 2025. PMID: 39616416 Free article.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Bührer E, Kicinski M, Mandala M, Pe M, Long GV, Atkinson V, Blank CU, Haydon A, Dalle S, Khattak A, Carlino MS, Meshcheryakov A, Sandhu S, Puig S, Schadendorf D, Jamal R, Rutkowski P, van den Eertwegh AJM, Coens C, Grebennik D, Krepler C, Robert C, Eggermont AMM. Bührer E, et al. Among authors: pe m. Lancet Oncol. 2024 Sep;25(9):1202-1212. doi: 10.1016/S1470-2045(24)00338-3. Epub 2024 Aug 12. Lancet Oncol. 2024. PMID: 39146951 Clinical Trial.
139 results